Physician Startup Accelerators: Solving Healthcare Challenges
- This article discusses the need for biomedical inventors to engage with the private sector to scale up their technologies and reach more people, especially given the potential for...
- * Funding Shift: Federal funding for biomedical innovation may decrease, making it crucial for inventors to find financially sustainable scaling solutions.
- In essence, the article advocates for a pragmatic approach to biomedical innovation, recognizing that achieving widespread impact frequently enough requires collaboration with, and acceptance of, the capitalist system.
Summary of the Article:
This article discusses the need for biomedical inventors to engage with the private sector to scale up their technologies and reach more people, especially given the potential for decreased federal funding.
Key takeaways:
* Funding Shift: Federal funding for biomedical innovation may decrease, making it crucial for inventors to find financially sustainable scaling solutions.
* Private Sector Necessity: Dr. Lam argues that while he isn’t inherently a capitalist, working with the private sector is often the only way to achieve large-scale impact and sustainability. He acknowledges the negative perception of the private sector within healthcare but believes it’s a reality that must be addressed.
* Clinical Translation: Engaging with the private sector is presented as the final, critical stage of translating biomedical research into real-world solutions.
* sustainability: The goal is to help as many people as possible in a sustainable manner, which requires navigating the financial realities of healthcare.
Disclosures:
* Bhargava and Klein have no financial disclosures.
* Lam and Tyburski are executives at Sanguina.
In essence, the article advocates for a pragmatic approach to biomedical innovation, recognizing that achieving widespread impact frequently enough requires collaboration with, and acceptance of, the capitalist system.